X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/accent-therapeutics-presents-data-supporting-two-lead-programs-at-aacr-2024-annual-meeting-302110786.html
https://www.prnewswire.com/news-releases/accent-therapeutics-to-present-data-supporting-dhx9-and-kif18a-as-compelling-therapeutic-targets-at-american-association-for-cancer-research-aacr-annual-meeting-2024-302095377.html
https://www.fiercebiotech.com/biotech/two-more-pharmas-practice-their-accent-invest-75m-series-c
https://www.prnewswire.com/news-releases/accent-therapeutics-announces-75-million-series-c-financing-to-advance-small-molecule-precision-cancer-therapies-302041338.html
https://www.prnewswire.com/news-releases/accent-therapeutics-unveils-xrn1-program-and-provides-pipeline-update-with-presentations-at-35th-aacr-nci-eortc-symposium-301951624.html
https://www.prnewswire.com/news-releases/accent-therapeutics-bolsters-leadership-team-with-key-executive-hires-301934280.html
https://www.prnewswire.com/news-releases/accent-therapeutics-to-present-data-supporting-dhx9-inhibition-as-a-novel-therapeutic-modality-at-american-association-for-cancer-research-aacr-annual-meeting-2023-301791256.html
https://endpts.com/langer-ciechanover-godfather-the-latest-ai-upstart-ipsen-forges-446m-aml-development-pact/
https://www.fiercebiotech.com/biotech/accent-astrazeneca-take-aim-at-rna-modifiers-55m-cancer-pact
Market Place
Share 
